1933 Industries Inc
CNSX:TGIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (1.4), the stock would be worth CA$0.01 (20% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.8 | CA$0.01 |
0%
|
| 3-Year Average | 1.4 | CA$0.01 |
-20%
|
| Industry Average | 10.4 | CA$0.06 |
+471%
|
| Country Average | 10.9 | CA$0.06 |
+504%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
1
|
1933 Industries Inc
CNSX:TGIF
|
5.2m CAD | 1.8 | 10.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
825.8B USD | 49.1 | 40 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
548.5B USD | 22.4 | 26.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 13.7 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.6B GBP | 19.6 | 27.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
218.9B CHF | 14.3 | 19.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.3B USD | 16.5 | 14.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 907.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 9.9 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
150.6B USD | 12.9 | 19.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.3B USD | 8.3 | 16.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 7.2 |
| Median | 10.9 |
| 70th Percentile | 17 |
| Max | 26 053.9 |
Other Multiples
1933 Industries Inc
Glance View
1933 Industries, Inc. is a vertically integrated cannabis company, which engages in the cultivation and production of medical marijuana. The company is headquartered in Vancouver, British Columbia and currently employs 76 full-time employees. The company went IPO on 2008-07-25. The firm operates through three segments: Alternative Medicine Association LLC (AMA), Infused Mfg LLC (Infused MFG), and Corporate. The AMA segment is focused on the cultivation and sale of medical and adult use cannabis products. The Infused MFG segment is focused on the manufacturing of Hemp derived cannabidiol (CBD) products. The firm's subsidiary, AMA is licensed in the State of Nevada as a cultivation facility; and a production facility for edible, or cannabis-infused products. Its subsidiary, Infused Mfg develops its own line of products under the Canna Hemp brand, which is carried in approximately 800 retail locations in the United States. The Canna Hemp portfolio includes Canna Hemp X a line targeting the actions sports market, and Canna Fused, which is a tetrahydrocannabinol (THC)-CBD product line.
